Hyderabad: Rheumatologist Dr. Liza Rajasekhar said that many people are suffering from rheumatoid arthritis due to lack of ...

GLP-1s aren't FDA-approved to treat rheumatoid arthritis, but many people notice improvement in their inflammation with the ...

Call it a double-dose of good news for Santa Clarita-based nerve-stimulating device maker SetPoint Medical Corp. On July 31, ...

Adults with vitiligo show a higher prevalence of thyroid disease, alopecia areata, rheumatoid arthritis, and type 1 diabetes, ...

Recently, researchers explored the value of blood-flow restricted resistance training for those with rheumatoid arthritis.

GLP-1s aren't FDA-approved to treat rheumatoid arthritis, but many people notice improvement in their inflammation with the ...

SaveHealth reports arthritis affects millions, involving joint inflammation and pain. Various types exist, with treatment ...

AbbVie said on Monday it would buy privately held Gilgamesh Pharmaceuticals' treatment for major depressive disorder in a deal worth up to $1.2 billion.

BOSTON & SAN FRANCISCO, August 21, 2025--(BUSINESS WIRE)--OM1, a leader in real-world evidence (RWE) generation and AI-driven ...

A team of scientists from Japan has identified hidden immune ‘hubs’ that drive joint damage in patients with rheumatoid ...

A cross-sectional study of RA patients in India finds 34.5% suffer from methotrexate intolerance, with symptoms often ...

Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is currently recruiting participants for a ...